Strong Growth At AHP At Start Of 1996
American Home Products recorded net income for the 1996 first quarter of $489.4 million and earnings per share of $1.55. Excluding the net gain of $623.9 million in the first quarter of 1995, net income rose 22.7%, and EPS advanced 19.2%.
Turnover for the quarter was $3.6 billion, up 4%. The following table shows results by major product category and industrial segment.
Sales % Rise- % Rise* (millions) -------------------------------------------------------------------------- Pharmaceuticals 1,962.1 - +5 Consumer health care 475.4 - +7 Medical devices 346.1 +23 +2 Total health care 2,783.6 +3 +5 Agricultural products 635.9 +9 +9 Food products 227.2 +18 +18 Net Sales 3,646.8 +4 +6 -------------------------------------------------------------------------- - As reported * Pro forma
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze